180 Life Sciences (ATNF) Stock Chart & Stock Price History $0.89 0.00 (-0.55%) Closing price 07/3/2025 03:52 PM EasternExtended Trading$0.89 +0.00 (+0.11%) As of 07/3/2025 04:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock 180 Life Sciences Stock Price Performance The 180 Life Sciences (ATNF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 42.76%, with a year-to-date return of -50.93%. In the past month, the stock has decreased 14.13%, reflecting recent market activity. As of the latest close, 180 Life Sciences traded at $0.89 with a market cap of $5.42 million and volume of 33,900 shares. Receive ATNF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for 180 Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.34%1 Month Performance-14.13%3 Month Performance+2.88%Year-To-Date Performance-50.93%1 Year Performance-42.76% ATNF Stock Chart for Sunday, July, 6, 2025 ATNF Chart by TradingView 180 Life Sciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$0.89$0.89$0.92$0.8833,900 shs$5.42 million07/03/2025$0.90$0.89-0.55%$0.92$0.8833,900 shs$5.42 million07/02/2025$0.89$0.90+0.89%$0.92$0.8835,460 shs$5.45 million07/01/2025$0.93$0.89-4.12%$0.94$0.8936,416 shs$5.40 million06/30/2025$0.83$0.93+11.83%$0.96$0.8345,296 shs$5.63 million06/27/2025$0.87$0.83-4.27%$0.85$0.8226,480 shs$4.73 million06/26/2025$0.88$0.87-1.45%$0.91$0.82101,653 shs$4.94 million06/25/2025$0.89$0.88-0.81%$1.04$0.8793,062 shs$5.02 million06/24/2025$0.87$0.89+2.54%$0.98$0.8740,340 shs$5.05 million06/23/2025$0.86$0.87+0.09%$0.92$0.8627,196 shs$4.93 million Get the Latest News and Ratings for ATNF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 180 Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025$0.88$0.86-1.81%$0.92$0.8618,806 shs$4.93 million06/19/2025$0.88$0.88$0.93$0.8747,046 shs$5.01 million06/18/2025$0.93$0.88-5.26%$0.93$0.8747,046 shs$5.02 million06/17/2025$0.96$0.93-3.23%$0.96$0.9032,064 shs$5.29 million06/16/2025$0.98$0.96-2.14%$0.99$0.9139,174 shs$5.47 million06/13/2025$1.00$0.98-1.90%$1.00$0.976,193 shs$5.59 million06/12/2025$0.99$1.00+1.01%$1.02$0.959,609 shs$5.70 million06/11/2025$1.04$0.99-4.81%$1.07$0.96115,743 shs$5.64 million06/10/2025$1.06$1.04-1.88%$1.09$1.0117,439 shs$5.92 million06/09/2025$1.04$1.06+1.91%$1.07$1.0127,511 shs$6.04 million06/06/2025$1.05$1.04-0.95%$1.09$1.0327,731 shs$5.92 million06/05/2025$1.07$1.05-1.80%$1.09$1.0318,354 shs$5.98 million Related Companies GBIO Stock Chart BCTX Stock Chart CALC Stock Chart NAII Stock Chart LGVN Stock Chart DRRX Stock Chart BLRX Stock Chart AYTU Stock Chart BIVI Stock Chart CGTX Stock Chart Receive ATNF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for 180 Life Sciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ATNF) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredFINAL HOURS: $9 Income ETF Access VANISHES at MIDNIGHTTHIS IS IT. Your FINAL CHANCE. At midnight, our 82% OFF July 4th deal disappears FOREVER. The countdown ...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 180 Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share 180 Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
